3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
33
Lung Neoplasms
13
Breast Neoplasms
12
Colorectal Neoplasms
11
Ovarian Neoplasms
10
Recurrence
9
Neoplasms
9
Small Cell Lung Carcinoma
8
Neoplasm Metastasis
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Lymphoma, Large B-Cell, Diffuse
7
Prostatic Neoplasms
6
Carcinoma, Hepatocellular
6
Triple Negative Breast Neoplasms
5
Pancreatic Neoplasms
5
Diabetes Mellitus, Insulin-Dependent, 12
5
Carcinoma
5
Multiple Myeloma
4
Lymphoma, Follicular
4
Cholangiocarcinoma
4
Uterine Cervical Neoplasms
3
Recurrent Squamous Cell Lung Carcinoma
3
Oropharyngeal Neoplasms
3
Mouth Neoplasms
3
Mesothelioma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Kidney Neoplasms
3
Interventions
Everolimus
5
Topotecan
2
Etoposide
2
Cisplatin
2
Bevacizumab
2
veliparib
1
pralsetinib
1
pertuzumab
1
pembrolizumab
1
pasireotide
1
lenvatinib
1
carfilzomib
1
cabozantinib
1
berzosertib
1
Temozolomide
1
Sunitinib
1
Specimen Handling
1
Radiotherapy
1
Radiosurgery
1
Podophyllotoxin
1
Platinum
1
Octreotide
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Irinotecan
1
Ipilimumab
1
Carboplatin
1
Capecitabine
1
CTLA-4 Antigen
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Neuroendocrine
×
durvalumab
×
Clear all
No trials found.